Quick Takeaways
- ARK Investment Management LLC filed SCHEDULE 13G/A for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX).
- Disclosed ownership: 7.2%.
- Date of event: 31 Dec 2025.
ARK Investment Management LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)
- Filing Manager
- ARK Investment Management LLC
- Reporting Manager
- ARK Investment Management LLC
- Symbol
- RXRX
- Shares outstanding
- 514,715,255 shares
- Disclosed Ownership
- 37,316,856 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 03 Feb 2026, 11:38:13 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARK Investment Management LLC disclosed 7.2% ownership in Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 03 Feb 2026, 11:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 7.2% | 37,316,856 | 35,278,842 | 592,161 | /s/ Kellen Carter | Kellen Carter, Chief Compliance Officer | |
| Catherine D. Wood | 7.2% | 37,316,856 | 0 | 35,871,003 | /s/ Catherine D. Wood | Catherine D. Wood, Chief Executive Officer, Chief Investment Officer |